IGC Pharma
29 hedge funds and large institutions have $3.97M invested in IGC Pharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $6.07M → $3.97M (-$2.11M)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
Holders
29
Holding in Top 10
–
Calls
$409K
Puts
$105K
Top Buyers
| 1 | +$39.5K | |
| 2 | +$25K | |
| 3 | +$14K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.49K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$710 |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$270K | |
| 3 | -$160K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$88K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$46.8K |